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Objective: The infiltration of mononuclear cells and replication and migration of smooth muscle cells (SMCs) from
media into the intima in the vascular wall are the cardinal pathological changes in the early stage of chronic
allograft nephropathy (CAN). But the mechanism is unclear. Therefore we investigated the role of matrix
metalloproteinase 9 (MMP-9) and its interaction with TGF-beta1, tubulointerstitial mononuclear cells infiltration and
migration of SMCs in the early stage of CAN.
Methods: Kidneys of Fisher (F334) rats were orthotopically transplanted into bilaterally nephrectomized Lewis (LEW)
recipients. To suppress an initial episode of acute rejection, rats were briefly treated with cyclosporine A (1.5 mg/kg/
day) for the first 10 days. Animals were harvested at 12 weeks after transplantation for histological,
immunohistochemistry and molecular biological analysis.
Results: The expression of MMP-9 was up-regulated in interstitium and vascular wall in the early stage of CAN,
where there were interstitial mononuclear cells infiltration and SMCs migration and proliferation. Moreover the
expression of MMP-9 were positively correlated with the degree of interstitial mononuclear cells infiltration, the
quantity of SMCs in arteriolar wall, and also the increased TFG-beta1 expression in the tubulointerstitium and
arteriolar wall.
Conclusions: MMP-9 may play an important role in the mechanism of pathological changes during the earlier
period of CAN.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/1582313332832700.
Keywords: Chronic allograft nephropathy (CAN), Mononuclear cells, Matrix metalloproteinase 9 (MMP-9),
Transforming growth factor-beta1 (TGF-beta1), Smooth muscle cells (SMCs)Introduction
Nowadays, it is well known that long-term renal allograft
survival is limited mainly by the progressive process
termed chronic allograft nephropathy (CAN) or chronic
rejection. Pathological features of CAN consist of diffuse
interstitial lymphocytes’ inflammation and fibrosis, glom-
erular mesangial matrix increase, glomerular sclerosis,
vascular intimal proliferation and tubular atrophy. The* Correspondence: hequnzou@hotmail.com
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reproduction in any medium, provided the orinfiltration of mononuclear cells and the migration of
smooth muscle cells (SMCs) from media into the intima
of the vascular wall are considered to be the cardinal
pathological changes during the early stage of CAN [1-4].
However, the mechanism is unclear. Thus, it is of great
significance to understand the underlying mechanism.
In other inflammatory diseases the remodeling of extra-
cellular matrix is a prerequisite for the migration of mono-
nuclear and other cells into the tissue. Gelatinase B
(matrix metalloproteinase-9, MMP-9) is a secreted multi-
domain enzyme that is important for the remodeling of
the extracellular matrix and the migration of normal and
tumor cells. It cleaves denatured collagens (gelatins) andThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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In the immune system, this cleavage helps lymphocytes and
other leukocytes to enter and move within the tissue [5].
MMP-9 belongs to the subfamily of MMPs that play an
important role in tissue remodeling in normal and patho-
logical inflammatory processes. MMP-9 is a major se-
cretion product of macrophages and a component of
cytoplasmic granules of neutrophils [6], and is also secreted
by lymphocytes and fibroblasts [7] and vascular SMC [8]
upon stimulation by inflammatory cytokines, such as TGF-
beta1, IL-1, TNF-α, MCP-1 and RANTES, etc. Our previ-
ous study had shown the role of RANTES in CAN [9].
Recently, it has been demonstrated that MMP-9 plays an
important role in the migration of mononuclear cells in
the tissue of some chronic inflammatory diseases [10-12].
MMP-9 can cleave basement membranes of blood vessel
and extracellular matrix. The increase of MMP-9 and
cleaved extracellular matrix segments parallels the infiltra-
tion of mononuclear cells [5]. MMP-9 produced by mono-
cytes and macrophages and plays an important role in the
inflammation [5]. In an experimentally induced animal
model of delayed-type hypersensitivity (DTH), injection of
MMP-9 lead to the infiltration of leukocytes [13].
Newby et al. provided direct evidence for the partici-
pation of MMP-9 in proliferation and migration of
SMCs (the process of arteriosclerosis) to the intima in
an in vitro experiment of rabbit’s aorta [14]. Aoyagi et al.
discovered that MMP-9 played an important role in the
migration of SMCs to the intima of the rabbit carotid
arteries after balloon denudation [15].
According to the close relations between MMP-9 and the
migration of mononuclear cells and SMC, it is very likely
that MMP-9 is also an important factor in the earlier stage
of CAN.
Thus, we investigated the expression and its role of




Animal research was approved by the Ethics Committee
of the Third Affiliated Hospital of Southern Medical
University. Naive inbred male rats weighing 200-250 g
(Experimental animal center of China, Peking) were used
throughout the experiments. Lewis (LEW) rats acted as
graft recipients and Fisher (F334) rats as donors. They
were housed under standard conditions at controlled
temperature, humidity and light/dark cycles, fed a stand-
ard diet and had free access to tap water.
Drugs
Cyclosporine A (Novartis Pharma AG, Basel, Switzerland)
was dissolved in cremophor and administered subcu-
taneously.Surgery
Operative procedures were performed under general
anesthesia induced by ketamine (100 mg/kg body weight;
Ketamin 2%, Huadong-Pharma, Shanghai, China) admi-
nistered intraperitoneally. The left donor kidney was
isolated, removed, cooled and positioned orthotopically
into the host whose left renal vessels had been isolated,
clamped, and the native kidney removed. Donor and
recipient renal artery, vein, and ureter were then anasto-
mosed end-to-end with 10–0 prolene sutures. No ureteral
stent was used. Mean ischemia time was 25 minutes
(ranges 22–31min). The remaining right kidney of the
recipient was removed on day 10, at which time the trans-
planted kidney was checked for surgical damage. Rats with
any overt signs of unsuccessful operation were discarded.
Experimental design
Ten male LEW rats received left renal transplantation
orthotopically from ten male F334 donors. To suppress
acute rejection, rats were treated with low dose CsA
(1.5 mg/kg/day) for the first 10 days. Ten uninephrecto-
mized male F334 rats and ten uninephrectomized male
LEW rats were used as control animals.
Functional measurements
At week 12, rats were put into metabolic cages and
24 hour urine samples were collected and quantitative
proteinuria was determined. At the same time, serum and
urine creatinine were measured and creatinine clearance
was calculated.
Harvesting
At week 12, recipients and controls were sacrificed and
the transplanted kidney removed. Only kidneys without
apparent complications of grafting such as pyeloneph-
ritis or hydronephrosis were evaluated. Representative
portions of the kidneys were snap-frozen in liquid nitro-
gen and stored at −80°C for PCR analysis or fixed in
formalin (4%) for histological and immunohistological
evaluation.
Histology
Formalin-fixed and paraffin embedded sections were
stained with hematoxylin/eosin to assess the grade of
cellular infiltration and tubular atrophy. Periodic acid-
Schiff (PAS) reaction was used to evaluate the extent
of glomerulo- and arterio-sclerosis. Tissue sections were
coded and examined in a blinded fashion by light mi-
croscopy. At least 200 glomeruli were counted in each
section. Renal structural damage was scored semiquan-
titatively on a scale from 0 to 3+ for interstitial cellular
infiltration, tubulopathy, glomerulopathy and arterial
intimal fibroplasia using the Banff criteria [16] and the
sum of scores (0–12+) was calculated for each sample.
Table 1 24-hour urine protein excretion, serum creatinie and creatinine clearence in transplant and control animals
N 24-hour urine protein Excretion (g/d) Serum creatinie (μ mol/L) Creatinine clearence (ml/min/100 g bw)
Transplant animals 10 0.025±0.028 96.2±36.4 0.180±0.097
controls(LEW) 10 0.035±0.016 74.3± 4.9 0.266±0.079a
controls(F334) 10 0.040±0.024 68.7±6.2a 0.297±0.070b
24-hour urine protein excretion did not differ between the transplant animals and F334 controls or LEW controls. The serum creatinine levels significantly differed
between transplant animals and F344 controls, but not between transplant animals and LEW controls. The levels of creatinine clearance in transplant animals
were significantly higher than those in either F344 controls or LEW controls (a P < 0.05, vs. allografts. b P < 0.01, vs. allografts).
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Goat anti-rat polyclonal antibodies MMP-9 and TGF-
beta1 are purchased from Santa Cruz (U.S.A.) and for
secondary and tertiary staining from DAKO (Denmark).
The antigen on the formalin-fixed and paraffin embed-
ded sections (2 μm) was restored by microwave, and
incubated with primary antibodies as mentioned above
using the LSAB techniques. The intensity of tissue stain-
ing for MMP-9 and TGF-beta1 was evaluated in a blinded
manner by calculating the relative stained area using a
computerized pathological image analytical system.
Images were acquired by means of Leica DMR-X mi-
croscope coupled to a Leica DC500 digital camera
(Leica, Wetzlar, Germany) and the image analysis system
Quantimet Q550 (Leica Imaging Systems). Ten ran-
domly selected discontinuous fields (400 ×) per kidney
were evaluated, including tubulointerstitial in renal cortex,Figure 1 The renal pathologic change of allografts and controls. Path
wall (C) in allografts and controls (D, E, and F, HE staining × 400).medulla and the conjunction region. More than 60 tubules
in each biopsy section were observed. The positive area
was yellow staining and Image-Pro Plus software was used
to quantify the integrated optical density. There were four
classed intensity of staining (negative vs. pale yellow vs.
pale brown vs. russet) and four classed staining area
(staining area < 25% vs. staining area 25–50% vs. staining
area 50–75% vs. staining area > 75%). product of intensity
and relevant staining area were used for statistical
analysis.RNA isolation
Total RNA was extracted from the representative portions
of the kidneys using Trizol (Gibco/BRL, U.S.A.), which
is based on the method described by Chomczynski and
Sacchi [17].ological changes of glomeruli (A), tubulointerstitium (B), and arteriolar
Figure 2 Histology change in allografts and controls. A The Banff sums of renal structural damage in allografts and controls. Rats in the
transplanted group developed a higher degree of renal interstitial fibrosis, tubulopathy, glomerulopathy and intimal proliferation. The Banff sum
of scores in allografts was significantly higher than that in either LEW controls or F344 controls. B The percentages of interstitial fibrosis in
allografts and controls (100 ×). There was no significant difference between the percentages of interstitial fibrosis of allografts and either F344
controls or LEW controls. C The quantity of interstitial mononuclear cells in allografts and controls (400 ×). The quantity of interstitial mononuclear
cells in allografts significantly increased compared to that of either F344 controls or LEW controls. D The quantity of vascular SMCs in the cortex
arteriolar wall of allografs and controls (× 400). The quantity of vascular SMCs in allografts was significantly increased compared to that of either
F344 controls or LEW controls.
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stored in −80°C. 60–100 mg frozen tissue samples were
homogenized in 1ml Trizol. 200 μl chloroform was
added to each mixture. The mixture was centrifuged at
12,000 g for 15 min at 4°C. The supernatant was treated
with 0.5 ml isopropanol. The mixture was centrifuged at
12,000 g for 10 min at 4°C. The supernatant was dis-
carded, and 0.75 ml 75% ethanol was added, and then
centrifuged at 7,500g for 5 min at 4°C. The precipitate
containing total RNA was stored at −80°C until further
processing. RNA concentration was measured spec-
trophotometrically.
Reverse transcription
Total RNA was transcribed to complementary DNA
(cDNA) by reverse transcription (RT) with hexamerrandom primers (Promega, U.S.A). 1 μg of total RNA
was added to 0.5 μg of primer. A reaction mixture con-
taining MMLV reverse transcriptase (Promega), buffer
solution (Promega), dNTP (Genda, Canada) in a concen-
tration of 0.2 mM/L, and 25U recombinant ribonuclease
inhibitor (Huamei, China). The reaction allowed to
proceed at 37°C for 60 minutes, and was stopped by heat-
ing to 95°C for 5 minutes followed by cooling on ice. The
cDNA was stored at −30°C for further procedure.
Amplification of specific complementary DNA (cDNA)
Specific cDNA products corresponding to mRNA for rat
β-actin, MMP-9 were amplified using the polymerase chain
reaction (PCR). 1 μl of cDNA was taken for PCR, which
was performed in PCR buffer (Genda), using 0.2 mM/L
dNTP (Genda), 1 μM/L of both primers (Genda), and
Figure 3 MMP mRNA expression in allografts and controls.
Analyzed by densitometric comparison to β-actin (internal control)
from the same sample after the positive image was digitized by video
for computerized densitometry. The results were given as a ratio of the
intensity of MMP-9 mRNA and β-actin mRNA. The expression MMP-9
mRNA was significantly increased in allografs compared to either F344
controls (P < 0.05) or LEW controls (P < 0.05).
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Thermal Cycler (U.S.A) was used for amplification with
the following sequence profile: initial denaturation at 95°C
for 5 minutes followed by relevant number of cycles of
three temperature PCR (denaturing, 94°C for 30 seconds;
annealing, 65°C for 30 seconds; and extension, 72°C for 30
seconds) ending with a final extension at 72°C for 7 min-
utes and cooling to 4°C.





(located at exon 4).
The length of the amplified segments was 270 bp;
MMP-9 :
up 50-ATCGACTCCAGTAGACAATCC-30 (located at
exon 9)
down 5 0-CAGAGAACTCGTTATCCAAGCG-3 0
(located at exon 12)
The length of the amplified segments was 443 bp.Gel electrophoresis
The amplified PCR product was identified by electro-
phoresis of 10 μl sample on 1.5% agarose gel stained
with 0.5 μg/ml of ethidium bromide. Sample products
were visualized by UV transillumination and the gel was
photographed. Specific products were identified by size
in relation to a known DNA MARKER (Takara Bio,
Dalian, China) run with each gel. MMP-9 cDNA was
semiquantitatively analyzed by densitometric compari-
son to β-actin (internal control) from the same sample
after the positive image was digitized by video for com-
puterized densitometry. The results are given as a ratio
of intensity of MMP-9 and β-actin mRNA.
Statistical analysis
All data were expressed as mean ± SD. Statistic analysis
was performed with statistical software (SPSS 13.0, Chicago,
IL), using One-Way ANOVA and bivariate correlation ana-




24-hour urine protein excretion did not differ between
the transplant animals and controls. 24-hour urine pro-
tein excretion of each group was given as mean ± SD.
There was no significant difference between the trans-
planted animals and two control groups (Table 1).
Serum creatinine levels in transplant animals and controls
We observed a tendency towards higher serum creatin-
ine levels in transplant rats. The serum creatinine levels
differed between transplant animals and F334 controls,
but not between transplant animals and LEW controls
(Table 1).
Creatinine clearance in transplant and control animals
We observed a tendency towards lower creatinine clear-
ance (ml/min/100 g bw) in transplanted rats. Creatinine
clearance in transplant animals was significantly higher
than those in either F334 controls or LEW controls
(Table 1).
Histological changes
At week 12 post-transplantation, transplant rats developed
a higher degree of mesangial expansion, glomerulosclearo-
sis and adhesions to Bowman’s capsule (Figure 1A),
tubulopathy and interstitial mononuclear cells infiltra-
tion (Figure 1B), and intimal proliferation in allografts
(Figure 1C). No abnormality was observed in glome-
ruli (Figure 1D), tubulointerstitium (Figure 1E) and
the arteries (Figure 1F) of F334 controls and LEW
controls.
Figure 4 Immunohistochemical localization of MMP-9 and TGF-beta1 in the kidney of allografts and controls. Immunohistochemical
analysis showed that MMP-9 and TGF-beta1 stained in tubulointerstitium and arteriolar walls of allografts and controls (A and C are MMP-9
staining in allografts, B and D are controls. E and G are TGF-beta1 staining in allografts, F and H are controls).
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The sum of these parameters such as glomerulopathy,
tubulopathy, interstitial mononuclear cell infiltration,
intersitial fibrosis, and intimal proliferation given as
Banff sum of scores, was significantly higher in allografts
than that in either F334 controls or LEW controls
(Figure 2A).
Interstitial fibrosis in allografts and controls
There was no significant difference between the percen-
tages of interstitial fibrosis in allografts and either F334
controls or LEW controls (Figure 2B).
The quantity of interstitial mononuclear cells in allografts
and controls
The quantity of interstitial mononuclear cells in allo-
grafts was significantly increased compared to that of
controls (Figure 2C).
The quantity of vascular smooth muscle cells in the wall of
renal cortex arteriole in allografts and controls
The quantity of vascular smooth muscle cells of allo-
grafts significantly increased compared to that of the
F334 controls and LEW controls (Figure 2D).
Molecular biology
We observed a tendency towards higher level of MMP-9
mRNA expression in transplant rats. The expression ofMMP-9 mRNA significantly increased in allografs com-
pared to either group of controls (Figure 3).
Immunohistochemistry
MMP-9 and TGF-beta1 immunostaining were observed in
glomeruli, tubulaointerstitium, and arterial wall (Figure 4A
and 4C are MMP-9 staining in allografts; Figure 4B and
4D are controls. Figure 4E and 4G are TGF-beta1 staning
in allografts; Figure 4F and 4H are controls).
MMP-9 expression in the kidneys of allografts and
controls at week 12 post-transplantation
The immunostaining of MMP-9 in tubulointerstitium of
allografts (0.325 ± 0.092) was significantly higher than
that of F344 controls (0.174 ± 0.052, P < 0.01) and LEW
controls (0.121 ± 0.047, P < 0.01) (Figure 5A).
The immunostaining of MMP-9 in arterial wall of allo-
grafts (0.095 ± 0.020) was significantly intense, compared
to that of F344 controls (0.070 ± 0.010, P < 0.05) and
LEW controls (0.049 ± 0.010, P < 0.05) (Figure 5B).
TGF-beta1 expression in the allografts and controls at 24
weeks
The immunostaining of TGF-beta1 in tubulointerstitium
of allografts (0.583 ± 0.100) was significantly intense, com-
pared to that of F334 controls (0.329 ± 0.107, P <0.01) and
LEW controls (0.336 ± 0.095, P < 0.01) (Figure 5C).
Figure 5 The expression of MMP-9 and TGF-beta1 in allografts and controls. A Expression of MMP-9 in the tubulointerstium of allografts
and controls (100 ×). . The immunostaining of MMP-9 in tubulointerstitium of allografts (0.325 ± 0.093) significantly increased compared to either
F344 controls (0.174 ± 0.052) and LEW controls (0.121 ± 0.047). B Expression of MMP-9 in the arteriolar wall of allografts and controls (100 ×). The
immunostaining of MMP-9 in arteriolar wall of allografts significantly increased compared to F344 control. C Expression of TGF-beta1 in the
tubulointerstium of allografts and controls (100 ×).The immunostaining of TGF-beta1 in tubulointerstitium of allografts significantly increased
compared to either F344 controls or LEW controls. D Expression of TGF-beta1 in the arteriolar wall of allografts and controls (100 ×). The
immunostaining of TGF-beta1 in arteriolar wall of allografts significantly increased compared to either F344 controls or LEW controls.
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allografts (0.086 ± 0.017) was significantly intense than
that of F344 controls (0.064 ± 0.010, P < 0.05) and LEW
controls (0.070 ± 0.012, P < 0.05) (Figure 5D).
Correlation analysis
The expression of MMP-9 mRNA and the degree of
mononuclear cells infiltration in allografs
We found positive correlation between the expression of
MMP-9 mRNA and degree of mononuclear cells infiltra-
tion in allografs by bivariate non-parameter correlation
analysis (r = 0.65, p < 0.05, Figure 6).
The immunostaining of MMP-9 in tubulointerstitium and
the quantity of interstitial mononuclear cells in allografts
We found positive correlation between the immunos-
taining of MMP-9 in tubulointerstitium and the quantity
of interstitial mononuclear cells in allografts by bivariatenon-parameter correlation analysis (r = 0.757, P < 0.05,
Figure 7A).The immunostaining of MMP-9 in renal arteriolar wall and
the quantity of vascular smooth muscle cells in allografts
We found positive correlation between the immunos-
taining of MMP-9 in arteriolar wall and the quantity of
vascular SMCs in allografts by bivariate non-parameter
correlation analysis (r = 0.741, P < 0.05, Figure 7B).The immunostaining of MMP-9 and TGF-beta1 in the
tubulointerstitium of allografts
We found positive correlation between the immunos-
taining of MMP-9 and TGF-beta1 in tubulointerstitium
of allografts by bivariate non-parameter correlation ana-
lysis (r = 0.810, P < 0.01, Figure 7C).
Figure 6 The correlation between the expression of MMP-9 mRNA and degree of mononuclear cells infiltration in allografts. MMP-9
mRNA level of allografts was demonstrated by MMP-9 mRNA/β-actin mRNA ratio, the degree of interstitial mononuclear cell infiltration was
evaluated according to Banff Criteria, as follow, 0 = No or trivial interstitial inflammation; 1 = up to 25% of parenchyma inflamed; 2 = 26% to 50%
parenchyma inflamed; 3 = > 50% parenchyma inflamed. The result of bivariate non-parameter correlation analysis demonstrated: the MMP-9
mRNA levels of allografts were correlated to the degrees of interstitial mononuclear cell infiltration. (P < 0.05, Spearman correlation coefficient
was 0.653).
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arteriolar wall of allografts
We found positive correlation between the immunos-
taining of MMP-9 and of TGF-beta1 in the arteriolar
wall of allografts by bivariate non-parameter correlation
analysis (r = 0.958, P < 0.001, Figure 7D).Discussion
The etiology of CAN is multifactorial and involves both
immune-dependent and immune-independent factors.
Immune-dependent factors include cell-mediated im-
mune responses and antibody-mediated responses to
donor antigens. Immune-independent factors include
donor characteristics, cold ischemia time, cytomegalo-
virus infection, hypertension, dyslipidemia, and the use
of calcineurin inhibitors (CNI), notably CsA, and more
recently Tac. In our present study, we didn’t found
T-cell infiltration and C4d sediment, so we focus on
the immune-independent injury of CAN. There has
Ahmedabad Tolerance Induction Protocol reported for
treatment of immune injuries of CAN [18], but in death
of reports for non-immune injury of CAN, since the
mechanism of which still needed to be fully revealed.
In the present study, we investigated the expression of
MMP-9 and its role, with F334 to LEW transplant rat
model, in the early stage (12 weeks post-transplantation)
of chronic allograft nephropathy which represents the
most common cause of late graft failure. We also inves-
tigated the correlation between MMP-9 expression and
the infiltration of mononuclear cells and SMCs replicationin the intima of vascular wall which are the cardinal
pathological changes of early stage of CAN [9,19,20].
It was shown in our data that MMP-9 expression was
upregulated in the early stage of CAN, at the same time
there was significant mononuclear cells infiltration in
the interstitium of allografts, and the MMP-9 expression
was correlated positively to the mononuclear cell infil-
tration and SMC replication. Studies in other disorders
such as tumor, atherosclerosis and many inflammatory
diseases indicate that extracellular matrix degradation
should be prerequisite for the migration of mononuclear
cells and other cells in the tissue, and the ability of
MMP-9 to degrade components of the extracellular
matrix and to regulate the activity of a number of sol-
uble proteins confers an important role in various
physiological and pathological processes [16]. Therefore,
the upregulated MMP-9 in the early stage of CAN,
showed in our data, might degrade extracellular matrix,
which further aggravate the mononuclear cells infiltra-
tion, and lead to tubulointerstitial fibrosis and chronic
renal failure eventually. We could conclude that MMP-9
might play an important role in the early stage of CAN,
the degradation of extracellular matrix caused by in-
creased expression of MMP-9 might be essential for the
migration and proliferation of mononuclear cells in the
early stage of CAN.
Our data suggest that upregulated MMP-9 expression in
the early stage of CAN has significant correlation with
SMC replication in the vascular intima of the allografts.
Bendeck MP et al. found that administration of a metallo-
proteinase inhibitor after injury resulted in a 97% reduction
Figure 7 The potential role of MMP in earlier stage of CAN. A The correlation between the immunostaining of MMP-9 in tubulointerstitium
and the quantity of interstitial mononuclear cells in allografts. The immunostaining of MMP-9 in tubulointerstitium was correlated to the quantity
of interstitial mononuclear cells in allografts (P < 0.05, Spearman correlation coefficient was 0.757). B The correlation between the
immunostaining of MMP-9 in arteriolar wall and the quantity of vascular SMCs in allografts. The immunostaining of MMP-9 in arteriolar wall was
correlated to the quantity of vascular SMC in allografts (P < 0.05, Spearman correlation coefficient was 0.741). C The correlation between the
immunostaining of MMP-9 and TGF-beta1 in the tubulointerstitium of allografts. The immunostaining of MMP-9 and TGF-beta1in
tubulointerstitium in allografts have correlation. (P < 0.01, Spearman correlation coefficient was 0.810). D The correlation between the
immunostaining of MMP-9 and TGF-beta1 in arteriolar wall of allografts. The immunostaining of MMP-9 and TGF-beta1 in arteriolar wall of
allografts have correlation. (P < 0.001, Spearman correlation coefficient was 0.958).
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carotid artery [21]. Recent research also provides evidence
that MMP-9-deficient aortic SMCs had not only decreased
the migratory activity, but also decreased the capacity to
make collagen contraction compared with wild-type cells
[22]. Cho A et al. found a denuding injury to the arteries of
wild-type mice promoted the medial SMC replication and
the migration of medial SMCs into the neointima, but
SMC replication was significantly lower, and SMC migra-
tion and arterial lesion growth were significantly impaired
in MMP-9 knockout arteries. SMCs, isolated from MMP-9
knockout mouse arteries, showed an impairment of migra-
tion and replication in vitro [23]. Thus, based on above
evidence, we can reach a conclusion that upregulated
MMP-9 expression in the early stage of CAN, shown with
our data, may breakdown vascular basement membraneand, therefore, is critical for the development of arterial
lesions of CAN by regulating both SMC migration and
proliferation.
Our data showed MMP-9 expression was positively
correlated to the increased TGF-beta1 expression in the
tubulointerstitium and arteriolar wall of the allografts. It
is well known that TGF-beta1 is a key fibrogenetic cyto-
kine involved in the pathogenesis of chronic renal allo-
graft dysfunction. It was demonstrated in mammary
cancer cells derived from Tenascin-C (TN-C) - deficient
mice, that TGF-beta1 induce MMP-9 expression in a
dose-dependent manner, and this inducement was sig-
nificantly enhanced by addition of TN-C. Neutralization
with specific anti-TGF-beta1 antibody showed decreased
expression of MMP-9, indicating that TGF-beta controls
the baseline MMP-9 expression by a direct autocrine
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sion by fibroblasts was induced by the addition of
TGF-beta1 or tumour necrosis factor (TNF)-alpha to the
culture medium [25]. Palosaari H et al. found TGF-beta1
significantly upregulated MMP-9 mRNA in odontoblasts
[26]. All the evidences above suggest that TGF-beta1 may
be one of the important causes leading to the upregulation
of MMP-9 expression in the early stage of CAN.
The pathological mechanism of CAN is complicated;
there are many contributors, such as MMPs and TIMPs
regulated extracellular matrix (ECM) synthesis and
degradation, introducing inflammation cells infiltration.
In our previous study [27], we found that matrix metallo-
proteinase-2 (MMP-2) and tissue inhibitor of metallopro-
teinase-1 (TIMP-1) were important cytokines for ECM
synthesis and degradation, and the excess accumulation of
ECM is the main pathological mechanism of fibrosis in
antibody-mediated renal graft rejection. Our present study
reveals that TGF-beta1 induced expression of mmp-9 may
induce mononuclear cells infiltration in the interstitium of
allografts and SMC replication. However, the signaling
pathway of MMPs and TIMPs regulate the synthesis and
degradation of ECM remains to reveal. We are going to
study the role of GSK-3β-β-actin signaling pathway,
because our pilot study had found that expression of GSK-
3β has positive correlation with either inflammatory cell
infiltration or interstitial fibrosis/tubular atrophy in human
renal allograft tissue [28]. Further studies are needed.Conclusions
MMP-9 may play an important role in the mechanism
of pathological changes during the earlier period of
chronic allograft nephropathy, and its expression may be
induced by TGF-beta1.
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